MedTrace Logo

Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid

NCT02891642 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-02-06

No results posted yet for this study

Summary

The purpose of the current study is to establish a Liquid biopsy method (positive enrichment by a novel immunomagnetic beads capture assay) for detection of malignant cell in serous effusions and to evaluate its sensitivity and specificity for clinical application.

Conditions

  • Malignancy
  • Pleural Effusion
  • Pleural Diseases
  • Ascites

Interventions

DEVICE

Immunomagnetic Detection

Immunomagnetic separation will be assessed through analysis of the percentage of positive samples identified compared to cytological techniques.

Sponsors & Collaborators

  • University of California, Los Angeles

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER

  • Jiangsu Cancer Institute & Hospital

    collaborator OTHER

  • Anhui Provincial Hospital

    collaborator OTHER_GOV

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • Renmin Hospital of Wuhan University

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Shiyang Pan, MD/ PhD · The First Affiliated Hospital with Nanjing Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891642 on ClinicalTrials.gov